DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Methotrexate Sodium Preservative Free is a drug marketed by Accord Hlthcare, Hospira, Mylan Labs Ltd, Pharmachemie Bv, Sagent Pharms Inc, Sandoz Inc, and West-ward Pharms Int. and is included in thirteen NDAs.
The generic ingredient in METHOTREXATE SODIUM PRESERVATIVE FREE is methotrexate sodium. There are twenty drug master file entries for this compound. Twenty-five suppliers are listed for this compound. Additional details are available on the methotrexate sodium profile page.
A generic version of METHOTREXATE SODIUM PRESERVATIVE FREE was approved as methotrexate sodium by WEST-WARD PHARMS INT on September 16th, 1986.
Summary for METHOTREXATE SODIUM PRESERVATIVE FREE
Recent Clinical Trials for METHOTREXATE SODIUM PRESERVATIVE FREE
Identify potential brand extensions & 505(b)(2) entrants
|Cooperative Study Group A for Hematology||Phase 3|